Douglas Murphy-Chutorian - 10 Dec 2024 Form 4 Insider Report for Semler Scientific, Inc. (SMLR)

Signature
/s/ Douglas Murphy-Chutorian
Issuer symbol
SMLR
Transactions as of
10 Dec 2024
Transactions value $
-$5,531,605
Form type
4
Filing time
12 Dec 2024, 16:15:40 UTC
Previous filing
12 Nov 2024
Next filing
07 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMLR Common Stock Options Exercise $481,885 +140,083 $3.44 140,083 10 Dec 2024 Direct
transaction SMLR Common Stock Sale -$3,034,433 -50,794 -36% $59.74 89,289 10 Dec 2024 Direct F1, F2
transaction SMLR Common Stock Sale -$772,004 -12,790 -14% $60.36 76,499 10 Dec 2024 Direct F1, F3
transaction SMLR Common Stock Sale -$647,990 -10,545 -14% $61.45 65,954 10 Dec 2024 Direct F1, F4
transaction SMLR Common Stock Sale -$54,254 -871 -1.3% $62.29 65,083 10 Dec 2024 Direct F1, F5
transaction SMLR Common Stock Options Exercise $51,314 +14,917 +23% $3.44 80,000 11 Dec 2024 Direct
transaction SMLR Common Stock Sale -$52,640 -891 -1.1% $59.08 79,109 11 Dec 2024 Direct F1, F6
transaction SMLR Common Stock Sale -$138,305 -2,294 -2.9% $60.29 76,815 11 Dec 2024 Direct F1, F7
transaction SMLR Common Stock Sale -$142,534 -2,315 -3% $61.57 74,500 11 Dec 2024 Direct F1, F8
transaction SMLR Common Stock Sale -$155,189 -2,489 -3.3% $62.35 72,011 11 Dec 2024 Direct F1, F9
transaction SMLR Common Stock Sale -$30,565 -500 -0.69% $61.13 71,511 11 Dec 2024 Direct F1, F10
transaction SMLR Common Stock Sale -$361,909 -5,811 -8.1% $62.28 65,700 11 Dec 2024 Direct F1, F11
transaction SMLR Common Stock Sale -$582,724 -9,254 -14% $62.97 56,446 11 Dec 2024 Direct F1, F12
transaction SMLR Common Stock Sale -$92,254 -1,446 -2.6% $63.8 55,000 11 Dec 2024 Direct F1, F13
transaction SMLR Common Stock Gift $0 -55,000 -100% $0 0 12 Dec 2024 Direct F14
transaction SMLR Common Stock Gift $0 +55,000 +55% $0 155,313 12 Dec 2024 See Footnote F14

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMLR Stock option (right to buy) Options Exercise $0 -140,083 -90% $0 14,917 10 Dec 2024 Common Stock 140,083 $3.44 Direct F15
transaction SMLR Stock option (right to buy) Options Exercise $0 -14,917 -100% $0 0 11 Dec 2024 Common Stock 14,917 $3.44 Direct F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold by the reporting person to cover the exercise price and withholding taxes.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.01 to $60.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.01 to $61.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.03 to $62.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.09 to $62.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.76 to $59.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.91 to $60.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (7) to this Form 4.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (8) to this Form 4.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (9) to this Form 4.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.54 to $61.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (10) to this Form 4.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.55 to $62.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (11) to this Form 4.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.55 to $63.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (12) to this Form 4.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.56 to $64.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (13) to this Form 4.
F14 Shares are held in a family trust over which Dr. Murphy-Chutorian is co-Trustee with his spouse, and with whom he shares voting and investment power over such securities.
F15 The shares underlying the option are fully vested and immediately exercisable.